USPTO trademark

DAXCERB

Opposition periodUSPTOWord markClass 5

"DAXCERB" is a word mark owned by Pfizer Inc., filed at the USPTO on September 1, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

View Pfizer Inc. portfolioGet this data via the API
Official USPTO record
DAXCERB trademark as filed
As filed with the USPTO
Status
Opposition period
Since October 27, 2026
Filed
September 1, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50083659
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns DAXCERB

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Pfizer Inc.

PFE · New York, United States

6,826 trademarks in the portfolioView company

Representative

Yana Gorbach

Goods and services

What the mark covers

The products and services DAXCERB is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorder; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of dermatomyositis

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Official gazette publication confirmation e-mailed
  2. Published for opposition
  3. Notification of notice of publication e-mailed
  4. Approved for pub - principal register
  5. Assigned to examiner
  6. New application office supplied data entered
  7. Application filing receipt mailed
  8. New application entered
FAQ

About DAXCERB

Who owns the trademark "DAXCERB"?

The USPTO trademark "DAXCERB" (application 50083659) is owned by Pfizer Inc.

What is the status of "DAXCERB"?

Its status at the USPTO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DAXCERB and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a06242-8157-7104-a669-08ff7667b87e
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a06242-8157-7104-a669-08ff7667b87e",
  "object": "trademark",
  "mark_text": "DAXCERB",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "US",
  "application_number": "50083659",
  "filing_date": "2026-09-01",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Pfizer Inc.",
      "entity_id": "ent_019f2853-15ff-713b-878b-ed770179b310"
    }
  ]
}